Govt may bar pharma firms from giving gifts to doctors

Department of Pharmaceuticals has prepared Uniform Code of Pharmaceuticals Marketing Practices

Image via Shutterstock
<a href="http://www.shutterstock.com/pic-86351161/stock-photo-many-pills-and-tablets-isolated-on-white-background.html" target="_blank">Image</a> via Shutterstock
Press Trust of India New Delhi
Last Updated : Oct 11 2015 | 12:24 PM IST
Pharma companies may soon be barred from giving any gift, cash or offer hospitality to doctors, as government is considering making it mandatory for them to follow uniform marketing practices code.

The Department of Pharmaceuticals has prepared the Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) and its voluntarily adoption and compilation was started from January 1 this year.

The code also prohibits companies from supplying drugs as samples, which are used to treat depression, inducing sleep such as hypnotic, sedative or tranquilliser.

Also Read

As per the code, the companies should not offer any gift or benefits in kind or offer foreign trips to doctors and if any firm was found following such practices, it could be expelled from the association.

"As of now it is voluntary for pharmaceuticals companies to follow UCPMP, but we are considering to make it compulsory in next few months," a senior government official told PTI.

A process has already been started to rework the entire code so that it could be make compulsory and the department will hold discussions for the same with all stakeholders including industry, Medical Council of India and others, the official added.

Discussions will also take place with Drug Controller General of India, Health Ministry and NGOs, the official said.

The marketing code which also cover medical devices sector was initially implemented from January 1 this year for a period of six months, which was extended for two months till August 31 and now has been extended for four months till December 31 this year.

As per the code, the companies can extend funding for medical research and study through approved institutions as per law and it should be fully disclosed.

The code also have stringent measures for audio video promotional activities and for the supply of free samples of medicines.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 11 2015 | 11:22 AM IST

Next Story